2022
Resolving icteric interference by a novel photoisomerization device: Bilibox
Vera MA, Koch CD, El-Khoury JM. Resolving icteric interference by a novel photoisomerization device: Bilibox. Clinical Biochemistry 2022, 115: 112-115. PMID: 35882276, DOI: 10.1016/j.clinbiochem.2022.07.004.Peer-Reviewed Original ResearchConceptsDirect bilirubinIcteric interferenceAforementioned analytesChemical reactivityPhotoisomerizationRoutine laboratory testingEndogenous interferencesBilirubin elevationBaseline creatinineAssay reagentsLaboratory testingDilutional methodMin of treatmentCreatinineEnzymatic creatinine assayIcterusBilirubinChemistry testingClinical samplesCreatinine assaysHeparin vacutainersTreatmentAnalytesIctericRepeat measurements
2021
Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population
Vera MA, Koch CD, Kavsak PA, El-Khoury JM. Determination of 97.5th and 99th percentile upper reference limits for heart-type fatty acid-binding protein (H-FABP) in a US population. Clinica Chimica Acta 2021, 523: 397-401. PMID: 34666029, DOI: 10.1016/j.cca.2021.10.011.Peer-Reviewed Original ResearchConceptsHeart-type fatty acid-binding proteinUpper reference limitPercentile upper reference limitClinical utilityReference limitsAcute kidney injuryHeart-type fatty acidAcute coronary syndromeAACC Universal Sample BankFatty acid-binding proteinH-FABP concentrationHealthy U.S.Coronary syndromeFinal sample populationKidney injuryAssay cutoffHealthy donorsAcid-binding proteinUS populationImmunoturbidimetric assayPotential biomarkersClinical sensitivityMyocardial tissueSerum samplesLow molecular weight proteins